Susan Molineaux is Director of Theravance Biopharma, Inc.. Currently has a direct ownership of 9,828 shares of TBPH, which is worth approximately $92,579. The most recent transaction as insider was on Apr 27, 2021, when has been sold 9,828 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.83K
0% 3M change
0% 12M change
Total Value Held $92,579

Susan Molineaux Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 27 2021
BUY
Grant, award, or other acquisition
-
9,828 Added 50.0%
9,828 Ordinary Shares

Also insider at

CALA
Calithera Biosciences, Inc. Healthcare
GERN
GERON CORP Healthcare
CYT
Cyteir Therapeutics, Inc. Healthcare
RPTX
Repare Therapeutics Inc. Healthcare
SM

Susan Molineaux

Director
South San Francisco, CA

Track Institutional and Insider Activities on TBPH

Follow Theravance Biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TBPH shares.

Notify only if

Insider Trading

Get notified when an Theravance Biopharma, Inc. insider buys or sells TBPH shares.

Notify only if

News

Receive news related to Theravance Biopharma, Inc.

Track Activities on TBPH